Mr Mrs Miss Ms Dr Other

Ms
Sabine
Rehaber

Project Manager

London Office

Operations

Telephone. +44 (0)207 7765148
Mobile. +44 (0)7788 712194
Email. srehaber@hgf.com

Experience

Sabine's expertise spans three decades working both in private practice and in-house IP departments, in several countries and in a variety of roles. Starting out as a certified IP paralegal, she has over the years developed significant experience and obtained qualifications in project management and process improvement, including its many useful applications for organisational structures and strategic decision-making processes. She works with the Executive and Board of HGF as well as with the operational teams to set up such structures to facilitate decision-making processes. She is also a certified business coach and trainer.

Industries

Services

CSR

Sabine is a member of I3PM, International Institute for IP Management and serves as committee chair for the organisation’s “IP Business Structure” committee.

She is also a member of IP Inclusive and has published various articles via their “Women in IP” committee on the emerging new roles in the IP landscape and integration of such new roles.

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.